Filter
389
Text search:
guidelines
for
pharmacovigilance
Featured
Recommendations
49
New Publications
115
Language
Document type
No document type
196
Guidelines
72
Studies & Reports
46
Strategic & Response Plan
32
Manuals
24
Training Material
7
Fact sheets
6
Situation Updates
3
Resource Platforms
1
Infographics
1
Online Courses
1
Countries / Regions
Kenya
23
Ghana
15
Uganda
15
India
14
Global
14
Western and Central Europe
13
Nigeria
12
Namibia
12
South Africa
11
Ethiopia
10
Eastern Europe
10
Nepal
9
Zambia
8
Rwanda
8
Sierra Leone
7
Tanzania
7
Malawi
7
Cambodia
5
South–East Asia Region
5
Latin America and the Carribbean
5
Liberia
4
Senegal
4
Bangladesh
4
Zimbabwe
3
Botswana
3
Lesotho
3
West and Central Africa
3
Russia
3
Congo, Democratic Republic of
2
Haiti
2
Philippines
2
Indonesia
2
Mozambique
2
Sudan
2
Eswatini/ Swaziland
2
Brazil
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Asia
2
Africa
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Cameroon
1
Togo
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Syria
1
Thailand
1
Gambia
1
Benin
1
Argentina
1
Burundi
1
Ukraine
1
Libya
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Bhutan
1
Southern Africa
1
Laos
1
Georgia
1
Vietnam
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
197
Clinical Guidelines
49
Public Health
9
Pharmacy & Technologies
8
Capacity Building
6
Women & Child Health
6
Key Resources
6
Toolboxes
TB
47
Pharmacy
44
AMR
32
Malaria
31
HIV
22
COVID-19
21
NTDs
17
NCDs
5
Rapid Response
3
Refugee
2
Caregiver
2
Planetary Health
2
Ebola & Marburg
1
Cholera
1
Polio
1
Specific Hazards
1
2.0 Rapid Response
1
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice
...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice
...
WHO Model Formulary
recommended
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditio
...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, res
...
This updated glossary for malaria aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for ma
...
Issue Brief: Neglected Tropical Diseases Part 2
recommended
In this subsequent part of the issue brief on the NTD Toolbox you will learn about general strategies, roadmaps, key
treatment guidelines, reports, and training material on Dengue & Chikungunya, Human African Trypanosomiasis and
Leprosy.
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector
...
An Act to provide for the efficient and comprehensive regulation and control of food, drugs, medical devices, cosmetics, herbal drugs and poisons and to repeal the Food
(Control of Quality) Act, 1978, the Pharmaceuticals and Poisons Act, 1978 and t
...
English version - This handbook sets out a the new paradigm for pharmacy practice. Its aim is to guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, w
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Access to safe, effective and quality-assured health products and technologies is crucial for achieving universal health coverage and primary health care goals. The continued growth of the aging population; increasing burden of noncommunicable disea
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for
...
Malaria in pregnancy is a significant health problem in malaria-endemic areas. It not only causes substantial childhood morbidity and mortality but also increases the risks of adverse events for pregnant women and their developing fetuses. Most of t
...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v
...
It is estimated that around 2 billion people worldwide do not have access to essential medicines. Access to medicines in the Eastern Mediterranean Region varies among countries, depending on their income level and allocation of domestic resources to medicine and vaccine procurement. Access to safe a
...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public
...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are
...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan
...